Published Articles & Presentations

Published Artciles & Presentations

The information in our publications and presentations should be considered accurate only as of the date of the publications or presentations. We disclaim any obligation to supplement or update the information in these publications and presentations.

To learn more about our innovative technology:
Exploratory Efficacy of INP104 in Migraine Patients by Prior Treatment

Presented at the PAINWEEK Conference, September 6-9, 2022 Authors: Tanya R. Bilchik, MD, FAHS; Robert Vann, PhD; Brett Downing, PhD; Sutapa Ray, PhD; Stephen B. Shrewsbury, MB ChB; Sheena K. Aurora, MD Introduction: Data suggests that patients are not satisfied…

READ MORE

Improvements in Productivity and Disability With INP104 as Assessed by the Migraine Disability Assessment Scale (MIDAS): Results From the Phase 3 STOP 301 Study

Presented at the PAINWEEK Conference, September 6-9, 2022 Authors: Christina Treppendahl, FNP-BC, AQH, MHD; Dawn C. Buse, PhD; Robert Vann, PhD; Christopher Fitzpatrick, PhD; Michelle Murphy, PhD; Stephen B. Shrewsbury, MBChB; Sheena K. Aurora, MD Introduction: As part of the…

READ MORE

Exploratory Efficacy of INP104 in Patients Using Concomitant Preventive Migraine Medications

Presented at the PAINWEEK Conference, September 6-9, 2022 Authors: Jihan Grant, MD; Robert Vann, PhD; Christopher Fitzpatrick, PhD; Stephen B. Shrewsbury, MB ChB; Sheena K. Aurora, MD Introduction: The exploratory efficacy of INP104 as an acute therapy for migraine has been…

READ MORE